Malaysia’s healthcare debate has traditionally been framed around two systems.
On one side is our public healthcare system, heavily subsidised and built on the principle that Malaysians should have access to healthcare regardless of their ability to pay; on the other is a large private healthcare sector offering greater choice, convenience, and capacity, but increasingly facing questions of affordability.
Both are important components of our healthcare system, yet both are also facing growing pressures. Public hospitals and clinics continue to shoulder the majority of the country’s healthcare needs while dealing with constraints in workforce, infrastructure and capacity, while private healthcare possesses considerable capacity and expertise but is becoming increasingly expensive for ordinary middle-income Malaysians.
This leaves us with an uncomfortable question. Must Malaysians ultimately choose between a public system that remains affordable but is ever more stretched, and a private system that offers greater convenience but is dauntingly expensive?
Perhaps the crux of the issues lies not within how much we spend on healthcare or whether healthcare should be delivered by the public or private sector, but how we have organised the healthcare market itself.
Instead of dividing healthcare purely according to ownership, we should also ask what different parts of the healthcare system are designed to achieve, what behaviours our financing arrangements encourage, and what outcomes we want the healthcare market to produce.
This is where the concept of a Social Market becomes useful. A Social Market is not an attempt to abolish the market, nor does it require the government to own every hospital or employ every doctor.
Private providers can continue to operate, generate revenue, and earn reasonable returns, but the important distinction lies in what the market rewards.
Much of private healthcare today operates through fee-for-service arrangements, where more investigations, procedures, and services generally translate into more revenue.
This does not mean that private hospitals or doctors deliberately provide unnecessary care, but economic incentives inevitably influence how any system develops, and a financing structure that primarily rewards activity will naturally behave differently from one that rewards efficiency, outcomes and value.
A Social Market would attempt to reshape those incentives so that providers can succeed commercially by treating more patients efficiently, maintaining good clinical outcomes, keeping costs predictable and making healthcare accessible to a broader segment of society.
Profit itself is therefore not the problem; the more important question is how that profit is generated.
A healthcare provider that improves productivity, uses its beds and operating theatres more efficiently, reduces unnecessary expenditure and treats more patients while maintaining clinical quality should be able to succeed commercially.
That is fundamentally different from a system where financial sustainability depends predominantly on generating more revenue from every episode of care. The objective is not to eliminate market forces from healthcare, but to organise those forces around a clearer social purpose.
Seen through this lens, MediAsas becomes much more interesting than just another medical insurance product placed on the shelf.
The proposed base medical and health insurance/takaful plan could become one of the first practical mechanisms through which Malaysia begins constructing such a Social Market, because its significance lies not only in providing another financing option for consumers but in using the way healthcare is financed to influence the behaviour of providers.
The proposed structure, in which policyholders would have access to preferred (or Tier 1) facilities with more affordable co-payments while retaining the ability to choose more expensive facilities with higher out-of-pocket contributions, preserves patient choice while beginning to differentiate providers according to value.
This distinction is important because financing can shape behaviour on both sides of the healthcare transaction.
If patients face lower co-payments when choosing hospitals that provide quality care at more reasonable and predictable prices, many will naturally gravitate towards those providers.
If sufficient patient volume follows, hospitals themselves gain a commercial reason to improve efficiency and compete for these patients.
MediAsas therefore has the potential to do something more consequential than simply paying medical bills. Here, it can begin creating a market in which providing better value becomes commercially attractive.
For that to happen, however, Tier 1 cannot become just another administrative label. Being recognised as a preferred provider must carry tangible value for hospitals, initially through greater patient demand generated by lower co-payments and, as the system matures, potentially through preferential contracting, larger patient pools, or more predictable patient volumes.
At the same time, Tier 1 status should not become an entitlement that a hospital acquires permanently. Providers should earn and retain their place through transparent measures of pricing, clinical quality, efficiency, patient outcomes and adherence to agreed standards, with periodic reassessment allowing hospitals to move into or out of the preferred network according to their performance.
Done properly, we will experience structured competition around value within the Malaysian healthcare market. Hospitals would continue competing on reputation, clinical expertise, facilities, and patient experience, but they would increasingly also compete on their ability to deliver good outcomes efficiently and at predictable costs.
Crucially, Tier 1 should never become synonymous with “cheap healthcare”, because the objective is not to create a lower-quality private healthcare network for middle-income Malaysians. It should instead become a marker of better-value healthcare, where affordability is achieved through efficiency and appropriate care rather than through compromising clinical quality.
This brings us to the more difficult technical question of how we determine what constitutes value in the first place. Malaysia cannot ask hospitals to compete on efficiency if purchasers themselves have limited ability to determine what an appropriate episode of care should cost, which is why the development of Diagnosis-Related Groups, or DRGs, becomes important.
By grouping healthcare episodes according to clinical conditions and expected resource requirements rather than simply paying for every individual service performed, DRGs can provide a framework for understanding the reasonable cost of treating different conditions and, eventually, allow purchasers to compare providers more meaningfully.
DRGs alone, however, will not solve medical inflation, nor should they be treated as a magic formula for healthcare reform.
Any payment mechanism can create unintended incentives if poorly designed, and focusing too heavily on keeping costs down may create a different problem if providers begin cutting back on necessary care.
This is why DRGs must be supported by other measures of quality, including clinical standards, patient outcomes and greater transparency in healthcare pricing.
Knowing how much an episode of care should cost is useful, but we must also know whether the patient received appropriate care and achieved a good outcome.
After all, a provider charging less but producing poorer outcomes is not delivering better value, just as a provider achieving excellent outcomes at unnecessarily high cost may not represent the best use of limited healthcare resources. If Malaysia wants providers to compete on value, we must first be able to measure both the cost and quality of the care being delivered.
How these measures are sequenced is therefore important. The Social Market provides the organising principle, MediAsas provides a potential financing mechanism, Tier 1 translates that financing architecture into incentives for providers, while DRGs, clinical benchmarks, outcomes, and data provide the infrastructure necessary for meaningful value-based purchasing.
Each component on its own will have limited impact, but together they create a different set of incentives within the system, where providers have stronger reasons to improve efficiency, purchasers have better tools to assess value, and patients have clearer signals when making healthcare choices.
Once we begin thinking about healthcare in this way, ownership also becomes less important than purpose.
A Social Market provider does not necessarily have to be privately owned, just as public ownership does not automatically guarantee efficiency or value.
Such providers could include conventional private hospitals willing to operate according to Social Market principles, NGOs or social enterprises, differentiated services operating within public facilities as initiatives such as RakanKKM evolve, or potentially institutions supported by long-term capital from government-linked investment companies and other institutional investors.
What should define their place within the Social Market is not who owns them, but whether they can consistently deliver quality healthcare efficiently and affordably.
This is important if public or institutional capital is eventually mobilised to expand affordable healthcare capacity.
A hospital supported by a GLC, GLIC, or other form of patient capital should not automatically receive Tier 1 status simply because of its ownership structure, nor should private ownership exclude a hospital from participating.
Every provider should ultimately have to demonstrate that it meets the required standards. The Social Market should therefore be defined by behaviour, incentives, and outcomes rather than ownership, because the objective is not to create another category of hospitals but to create a different way for healthcare providers to compete.
Over time, this allows us to imagine Malaysian healthcare not as two competing systems but as three complementary spaces. The public healthcare system remains the foundation, providing universal access, population health services, and the country’s ultimate healthcare safety net; a Social Market can occupy the space between fully subsidised public care and premium private healthcare, serving Malaysians who want access to private capacity but require greater affordability and predictability; while the premium market can continue serving those willing and able to pay more for additional choice, amenities, or services.
These three spaces do not need to compete for ideological supremacy because they perform different functions within the same healthcare ecosystem.
The role of government in such a system also becomes clearer. The government does not necessarily need to own every hospital or finance every episode of care directly, but it must be an effective steward of the healthcare system by setting the rules, designing the right incentives, monitoring quality and outcomes, and ensuring that both public and private capacity contribute towards our national healthcare needs.
This stewardship role is already outlined in the Health White Paper, and will become increasingly important as Malaysia’s population ages, demand for healthcare grows and the government faces greater pressure on its limited fiscal resources.
Malaysia cannot simply spend its way out of every healthcare challenge, just as we cannot assume that leaving healthcare entirely to market forces will inevitably produce affordable or equitable care.
The more useful question is whether we can shape those market forces differently, and MediAsas gives us an opportunity to begin testing exactly that. Its eventual significance should therefore be measured by more than the number of policies sold or the premiums charged; the more consequential test will be whether it changes how healthcare is purchased, how providers compete, and ultimately what our healthcare market rewards.
If healthcare providers can succeed by treating more Malaysians efficiently, maintaining good outcomes, and keeping care affordable rather than simply earning more from every Malaysian they treat, we begin to create something that has long been missing between public and premium healthcare.
The reform Malaysia needs may therefore be less about choosing between government and the market, and more about building a market in which commercial success and social purpose increasingly point in the same direction.
Dr Sean Thum is a policy officer at the Ministry of Communications.